Investment firm focused on medical and technology sectors
Concentrated portfolio of companies
Recently delisted from Aim
What Amphion does
Amphion Innovations PLC (LON:AMP) is an investment company that focuses on helping build companies in the medical and technology sectors.
The firm currently has shareholdings in seven partner companies that are developing technologies targeting what it says are “substantial commercial marketplaces”.
.
What Amphion owns
The company has stakes in six partner companies;
1. Axcess International – 15.07% stake – provides wireless systems that help monitor business activity in real-time in sectors such as transport and security
2. FireStar Software – 11.86% stake – develops software the helps companies to integrate and exchange data electronically in a private, secured structure
3. PrivateMarkets – 25.33% stake – an online marketplace that links buyers and sellers of physical commodities such as gold and copper
4. WellGen – 24.34% stake – develops foods designed to help treat inflammation-based illnesses. The company also has a proprietary black tea extract that has been demonstrated to improve performance and recovery benefits such as a reduction in muscle soreness and reduced recovery time
5. DataTern – 100% stake – a company established for Amphion to commercialise intellectual properties that originate from its portfolio companies
6. Motif Bio PLC (LON:MTFB) – below 3% – an antibiotic developer focusing on diseases caused by drug-resistant bacteria
Inflexion points
- Amphion recently paid back a loan facility through sale of its stake in listed group Polarean
- Shares delisted from AIM at end of 2019
- Company is looking for an additional source of finance